In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, the ...

For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...

Benefits include reduced polyp size and severity of nasal symptoms at 24 weeks. HealthDay News — In adults with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal ...

Among patients with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, stapokibart, a novel monoclonal antibody, reduced polyp size and severity of nasal ...

For nearly a decade, 71-year-old Ho Thian Kong struggled with the effects of chronic rhinosinusitis with nasal polyps, a ...

Among patients with severe chronic rhinosinusitis with nasal polyps treated with a daily intranasal corticosteroid, stapokibart, a ...